Melanoma MRI: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{YD}}; {{SSK}} | {{CMG}} {{AE}} {{YD}}; {{SSK}} | ||
==Overview== | ==Overview== | ||
MRI can be useful in the staging of brain and liver metastases. Brain MRI may be considered for the diagnosis of metastatic lesions in patients who have been diagnosed with stage IA-IV melanoma and for secondary prevention of melanoma in patients who were previously diagnosed with Stage IIB-IV melanoma (annually for 5 years). | |||
==MRI== | ==MRI== | ||
*MRI can be useful in the staging of brain and liver metastases.<ref name="NanniFantini2010">{{cite journal|last1=Nanni|first1=C.|last2=Fantini|first2=L.|last3=Nicolini|first3=S.|last4=Fanti|first4=S.|title=Non FDG PET|journal=Clinical Radiology|volume=65|issue=7|year=2010|pages=536–548|issn=00099260|doi=10.1016/j.crad.2010.03.012}}</ref> | |||
*Brain MRI is recommended for diagnosis of metastatic lesions in the following conditions:<ref name="pmid23584343">{{cite journal| author=Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A et al.| title=Melanoma, version 2.2013: featured updates to the NCCN guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 4 | pages= 395-407 | pmid=23584343 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23584343 }} </ref> | *Brain MRI is recommended for the diagnosis of metastatic lesions in the following conditions:<ref name="pmid23584343">{{cite journal| author=Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A et al.| title=Melanoma, version 2.2013: featured updates to the NCCN guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 4 | pages= 395-407 | pmid=23584343 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23584343 }} </ref> | ||
:* | :*In patients who have been diagnosed with stage IA-IV melanoma | ||
:*For secondary prevention of melanoma | :*For secondary prevention of melanoma in patients who were previously diagnosed with Stage IIB-IV melanoma (annually for 5 years) | ||
==References== | ==References== | ||
Revision as of 18:35, 4 January 2019
|
Melanoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanoma MRI On the Web |
|
American Roentgen Ray Society Images of Melanoma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
Overview
MRI can be useful in the staging of brain and liver metastases. Brain MRI may be considered for the diagnosis of metastatic lesions in patients who have been diagnosed with stage IA-IV melanoma and for secondary prevention of melanoma in patients who were previously diagnosed with Stage IIB-IV melanoma (annually for 5 years).
MRI
- MRI can be useful in the staging of brain and liver metastases.[1]
- Brain MRI is recommended for the diagnosis of metastatic lesions in the following conditions:[2]
- In patients who have been diagnosed with stage IA-IV melanoma
- For secondary prevention of melanoma in patients who were previously diagnosed with Stage IIB-IV melanoma (annually for 5 years)
References
- ↑ Nanni, C.; Fantini, L.; Nicolini, S.; Fanti, S. (2010). "Non FDG PET". Clinical Radiology. 65 (7): 536–548. doi:10.1016/j.crad.2010.03.012. ISSN 0009-9260.
- ↑ Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A; et al. (2013). "Melanoma, version 2.2013: featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (4): 395–407. PMID 23584343.